Sysmex Europe SE will be part of AD/PD™ from 17-21 March 2026!
The Alzheimer’s Disease and Parkinson’s Disease Conference will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and related neurological disorders.
With HISCL™, Sysmex offers a streamlined alternative with blood-based biomarkers to support earlier and more equitable detection of Alzheimer’s disease.
Visit our booth to get more insights supporting early Alzheimer’s diagnosis for your patients.
In addition, Sysmex is delighted to invite you to its theatre presentation at the AD/PD™:
- Date: Friday 20 March
- Time: 10:40 - 11:10 (During the coffee break)
- Location: In the coffee break product theatre area
Title: Advancing accessible Alzheimer’s diagnosis with high-performing blood biomarker
Speaker: Dr Daniel Alcolea: Sant Pau Memory Unit, Hospital Sant Pau in Barcelona
Title: Practical applicability of the Aβ42/Aβ40 ratio in a large outpatient laboratory: real-world experience
Speaker: Dr Georg Endler: Labors.at, Vienna
Know more about Sysmex’s role in Alzheimer’s disease diagnosis: Alzheimer’s disease